Immunogenicity of peptides of measles virus origin and influence of adjuvants

Vaccine

Volumn 24, Issue 2, 2006, Pages 185-194

  Halassy, Beata ^a   Mateljak, Sanja ^a   Bouche, Fabienne B ^b   Pütz, Mike M ^b   Muller, Claude P ^b   Frkanec, Ruža ^a   Habjanec, Lidija ^a   Tomašić, Jelka ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

^b LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

Author keywords

Epitope based vaccines; Measles virus; Peptide co immunisation; Peptidoglycan monomer

Indexed keywords

EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; LEUCYLLEUCYLGLYCYLISOLEUCYLLEUCYLGLUTAMYLSERYLARGINYLGLYCYLISOLEUCYLLYSYL ALANYLARGINYLISOLEUCYLTHREONINE; LEUCYLSERYLGLUTAMYLISOLEUCYLLYSYLGLYCYLVALYLISOLEUCYLVALYLHISTIDYLARGINYL LEUCYLGLUTAMYLGLYCYLVALINE; LYSYLPROLYLASPARAGINYLLEUCYLSERYLSERYLLYSYLARGINYLSERYLGLUTAMYLLEUCYLSERYL GLUTAMINYLLEUCYLSERINE; NUCLEOPROTEIN; PEPTIDOGLYCAN; PROLYLVALYLVALYLGLUTAMYLVALYLASPARAGINYLGLYCYLVALYLTHREONYLISOLEUCYL GLUTAMINYLVALYLGLYCYLSERYLARGININE; TYROSYLALANYLMETHIONYLGLYCYLVALYLGLYCYLVALYLGLUTAMYLLEUCYLGLUTAMYL ASPARAGINE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG STRUCTURE; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MEASLES VIRUS; MICE; NEUTRALIZATION TESTS; PEPTIDES;

EID: 28644441907     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.057     Document Type: Article

References (49)

1. E.H. Beachey, J.M. Seyer, J.B. Dale, W.A. Simpson, and A.H. Kang Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein Nature 292 1981 457 459
2. R. DiMarchi, G. Brooke, C. Gale, V. Cracknell, T. Doel, and N. Mowat Protection of cattle against foot-and-mouth disease by a synthetic peptide Science 232 1986 639 641
3. M.F. Good, W.L. Maloy, M.N. Lunde, H. Margalit, J.L. Cornette, and G.L. Smith Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein Science 235 1987 1059 1062
4. D.R. Milich, J.L. Hughes, A. McLacnlan, G.B. Thornton, and A. Moriarty Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B cell epitope Proc Natl Acad Sci USA 85 1988 1610 1614
5. E.A. Emini, V. Larson, J. Eichberg, P. Conard, V.M. Garsky, and D.R. Lee Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein J Med Virol 28 1989 7 12
6. M.K. Hart, T.J. Palker, T.J. Matthews, A.J. Langlois, N.W. Lerche, and M.E. Martin Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys J Immunol 145 1990 2677 2685
7. J.P. Langeveld, J.I. Casal, A.D. Osterhaus, E. Cortes, R. de Swart, and C. Vela First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs J Virol 68 1994 4506 4513
8. C.Y. Wang, T.Y. Chang, A.M. Walfield, J. Ye, M. Shen, and S.P. Chen Effective synthetic peptide vaccine for foot-and-mouth disease in swine Vaccine 20 2002 2603 2610
9. C.D. Partidos, C.M. Stanley, and M.W. Steward Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins J Gen Virol 72 1991 1293 1299
10. O.E. Obeid, C.D. Partidos, C.R. Howard, and M.W. Steward Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus J Virol 69 1995 1420 1428
11. C. Partidos, C. Stanley, and M. Steward The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequences Mol Immunol 29 1992 651 658
12. D. Ziegler, P. Fournier, Berbers GAH, H. Steuer, K-H. Weismüller, and B. Fleckenstein Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies J Gen Virol 77 1996 2479 2489
13. K.C. El-Kasmi, D. Theisen, N.H.C. Brons, and C.P. Muller The molecular basis of virus crossreactivity and neutralisation after immunization with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein Mol Immunol 35 1998 905 918
14. M.M. Putz, J. Hoebeke, W. Ammerlaan, S. Schneider, and C.P. Muller Functional fine-mapping and molecular modelling of a conserved loop epitope of the measles virus hemagglutinin protein Eur J Biochem 270 2003 1515 1527
15. M.M. Putz, W. Ammerlaan, F. Schneider, G. Jung, and C.P. Muller Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens Vaccine 22 2004 4173 4182
16. K.C. El Kasmi, D. Theisen, N.H.C. Brons, W. Ammerlaan, M. Klingele, and A.T. Truong A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis Vaccine 17 1999 2436 2445
17. K.C. El Kasmi, S. Fillon, D.M. Theisen, H. Hartter, N.H.C Brons, and C.P. Muller Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies J Gen Virol 81 2000 729 735
18. M.M. Putz, and C.P. Muller The rationale of a peptide-conjugate vaccine against measles Vaccine 21 2003 663 666
19. M.M. Putz, F.B. Bouche, R.L. de Stewart, and C.P. Muller Experimental vaccines against measles in a world of changing epidemiology Int J Parasitol 33 2003 525 545
20. F.B. Bouche, O.T. Ertl, C.P. Muller, and Neutralizing B cell response in measles Viral Immunol 15 2002 451 471
21. S.F. Atabani, O.E. Obeid, D. Chargelegue, P. Aaby, H. Whittle, and M.W. Steward Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection J Virol 71 1997 7240 7245
22. P. Fournier, N.H.C. Brons, G.A.M. Berbers, K-H. Weismüller, B.T. Fleckenstein, and F. Schneider Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis J Gen Virol 78 1997 1295 1302
23. S. Deroo, K.C. El Kasmi, P. Fournier, D. Theisen, N.H.C. Brons, and M. Herrmann Enhanced antigenicity of four-contact-residue epitope of the measles virus hemagglutinin protein by phage display libraries: evidence of a helical structure in the putative active site Mol Immunol 35 1998 435 443
24. C.D. Partidos, and M.W. Steward Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans J Gen Virol 71 1990 2099 2105
25. P.C. Ho, D.A. Mutch, K.D. Winkel, A.J. Saul, G.L. Jones, and T.J. Doran Identification of two promiscuous T cell epitopes from tetanus toxin Eur J Immunol 20 1990 477 483
26. C.D. Partidos, J. Ripley, A. Delmas, O.E. Obeid, A. Denbury, and M.W. Steward Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model J Gen Virol 78 1997 3227 3232
27. D. Keglević, B. Ladešić, O. Hadžija, J. Tomašić, Z. Valinger, and M. Pokorny Isolation and study of the composition of a peptidoglycan complex excreted by the biotin-requiring mutant of Brevibacterium divaricatum NRRL-2311 in the presence of penicillin Eur J Biochem 42 1974 389 400
28. D. Keglević, B. Ladešić, J. Tomašić, Z. Valinger, and R. Naumski Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant Biochim Biophys Acta 585 1979 273 281
29. J. Tomašić, L.J. Sesartić, S.A. Martin, Z. Valinger, and B. Ladešić Comparative susceptibility of a peptidoglycan monomer from Brevibacterium divaricatum and its anhydromuramyl analogue to hydrolysis with N-acetylmuramyl-L-alanine amidase J Chromatogr 440 1988 405 414
30. H. Matter, L. Szilagyi, P. Forgo, Ž Marinić, and B. Klaić Structure and dynamics of a peptidoglycan monomer in aqueous solution using NMR spectroscopy and simulated annealing calculations J Am Chem Soc 119 1997 2212 2223
31. J. Tomašić, I. Hanzl-Dujmović, B. Špoljar, B. Vranešić, M. Šantak, and A. Jovičić Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse Vaccine 18 2000 1236 1243
32. D. Ljevaković, J. Tomašić, V. Šporec, B. Halassy Špoljar, and I. Hanzl-Dujmović Synthesis of novel adamantylacetyl derivative of peptidoglycan monomer - biological evaluation of immunomodulatory peptidoglycan monomer and respective derivatives with lipophilic substituents on amino group Bioorg Med Chem 8 2000 2441 2449
33. B. Halassy, M. Krstanović, R. Frkanec, and J. Tomaš ić Adjuvant activity of peptidoglycan monomer and its metabolic products Vaccine 21 2003 971 976
34. B. Halassy Špoljar, T. Čimbora, I. Hanzl-Dujmović, B. Dojnović, A. Sabioncello, and M. Krstanović Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice Vaccine 20 2002 3543 3550
35. J. Aucouturier, L. Dupuis, S. Deville, S. Ascarateil, and V. Ganne Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines Expert Rev Vaccines 1 2002 111 118
36. S.J. Cox, N. Aggarwal, R.J. Statham, and P.V. Barnett Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines Vaccine 21 2003 1336 1347
37. d-restricted peptides define the same immunodominant region of the measles virus Mol Immunol 32 1995 37 47
38. P. Fournier, W. Ammerlaan, D. Ziegler, C. Giminez, C. Rabourdin-Combe, and B.T. Fleckenstein Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides Int Immunol 8 1996 1441 1451
39. K.H. Wiesmuller, G. Spahn, D. Handtmann, F. Schneider, G. Jung, and C.P. Muller Heterogeneity of linear B cell epitopes of the measles virus fusion protein reacting with late convalescent sera J Gen Virol 73 1992 2211 2216
40. M. Krstanović, R. Frkanec, B. Vranešić, D. Ljevaković, V. Šporec, and J. Tomašić Reversed-phase high-performance liquid chromatographic method for the determination of peptidoglycan monomers and structurally related peptides and adamantyltripeptides J Chromatogr B 773 2002 167 174
41. P.P.A.M. Leenars, C.F.M. Hendriksen, W.A. de Leeuw, F. Carat, P. Delahaut, and R. Fischer The production of polyclonal antibodies in laboratory animals. The report and recommendations of ECVAM workshop 35 ATLA 27 1999 79 102
42. Mahy BWJ, Kangro HO. Virus isolation and quantitation. Quantitation of virus. In: Virology Methods Manual. London, San Diego, New York Boston, Sydney, Tokyo, Toronto: Harcourt Brace&Company; 1996. p. 35-46.
43. S.P. Wright Adjusted p-values for simultaneous inference Biometrics 27 1992 77 81
44. P.E. Jensen, and J.A. Kapp Bystander help in primary immune responses in vivo J Exp Med 164 1986 841 854
45. M.F. Good, D. Pombo, M.N. Lunde, W.L. Maloy, R. Halenbeck, and K. Koths Recombinant human IL-2 overcomes genetic non-responsiveness to malaria sporozoite peptides. Correlation of effect with biological activity of IL-2 J Immunol 141 1988 972 977
46. P. Sarobe, J.J. Lasarte, J. Golvano, A. Gullón, M-P. Civeira, and J. Prieto Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide Eur J Immunol 21 1991 1555 1558
47. C.D. Partidos, O.E. Obeid, and M.W. Steward Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides Immunology 77 1992 262 266
48. D.M. Shaw, C.M. Stanley, C.D. Partidos, and M.W. Steward Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization Mol Immunol 30 1993 961 968
49. N.H.C. Brons, A. Blaich, K.H. Wiesmuller, F. Schneider, G. Jung, and C.P. Muller Hierarchic T-cell help to non-linked B-cell epitopes Scand J Immunol 44 1996 478 484